Patents by Inventor Andrew R. Blight

Andrew R. Blight has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS
    Publication number: 20100324098
    Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.
    Type: Application
    Filed: June 25, 2010
    Publication date: December 23, 2010
    Inventors: Andrew R. BLIGHT, Ron COHEN
  • SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS
    Publication number: 20100324100
    Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.
    Type: Application
    Filed: June 25, 2010
    Publication date: December 23, 2010
    Inventors: Andrew R. BLIGHT, Ron COHEN
  • SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS
    Publication number: 20100324099
    Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.
    Type: Application
    Filed: June 25, 2010
    Publication date: December 23, 2010
    Inventors: Andrew R. BLIGHT, Ron COHEN
  • METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS
    Publication number: 20100061935
    Abstract: Disclosed herein are methods and compositions related to use of aminopyridines, such as fampridine, to improve impairments of patients with a demyelinating condition, such as MS.
    Type: Application
    Filed: September 10, 2009
    Publication date: March 11, 2010
    Applicant: ACORDA THERAPEUTICS, INC.
    Inventors: Andrew R. Blight, Ron Cohen
  • Method, apparatus and solftware for identifying responders in clinical environment
    Publication number: 20090150180
    Abstract: A process for determining responders in clinical testing environments that involves, inter alia, detecting treatment response through the use of small numbers of measurements of randomly varying outcome variables in individual clinical trial subjects, and by analyzing the measurements in such a way as to eliminate troublesome variables, such as a spontaneous population variability.
    Type: Application
    Filed: September 25, 2006
    Publication date: June 11, 2009
    Inventors: Ron Cohen, Andrew R. Blight, Lawrence Marinucci
  • Use of 4-aminopyridine in the reduction of chronic pain and spasticity in a spinal cord injured patient
    Patent number: 5545648
    Abstract: A method of reducing chronic pain and spasticity in a spinal cord injured patient by the administration of 4-aminopyridine is disclosed.
    Type: Grant
    Filed: September 13, 1994
    Date of Patent: August 13, 1996
    Assignee: Canadian Spinal Research Organization
    Inventors: Robert R. Hansebout, Andrew R. Blight